P-n diodes are two-terminal devices that consist of two types of semiconductor materials (i.e., a p-type and an n-type ...

The team simulated a living cell at nanoscale resolution and recapitulated how every molecule within that cell behaved over the course of a full cell cycle. The work took many years: vast computer ...

NORTH CHARLESTON, S.C. (WCIV) — Traffic is partially blocked on both I-526 westbound and I-26 westbound after a tractor trailer with a high load struck a sign on I-526 westbound just before Rivers ...

Lanes have reopened on Highway 50 in Sacramento after being blocked due to a big rig leaking oil, according to the California Highway Patrol. CHP said the truck spilled its load on westbound Highway ...

Gilead Sciences is expanding its cell therapy pipeline and technological capabilities through the $7.8 billion acquisition of Arcellx, its partner in the development of a multiple myeloma treatment ...

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple sclerosis (MS), a chronic autoimmune disease that affects nearly one million ...

Never miss a story with The Brief, our free newsletter. Independent Texas reporting needs your support. Help us bring you and millions of others in-depth news and information. Will you join our ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which ...

A map of the immune cell landscape found in the bone marrow of patients with multiple myeloma could shed light on how the immune system interacts with cancerous plasma cells. It could also help ...

Higher levels of CD4-positive naïve T cells in patients receiving CAR T-cell therapy for multiple myeloma are associated with longer PFS, suggesting T-cell composition may serve as a biomarker to ...

Dec 10 (Reuters) - (This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive the full newsletter in your inbox for free sign up ...

The chimeric antigen receptor (CAR) T cell therapy anitocabtagene autoleucel (anito-cel) continued to show strong results in treating relapsed/refractory multiple myeloma, according to new trial data ...